A detailed history of Armbruster Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Armbruster Capital Management, Inc. holds 16,335 shares of PFE stock, worth $436,471. This represents 0.09% of its overall portfolio holdings.

Number of Shares
16,335
Holding current value
$436,471
% of portfolio
0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$27.7 - $31.39 $452,479 - $512,755
16,335 New
16,335 $472,000
Q3 2023

Oct 17, 2023

SELL
$32.09 - $37.51 $48,776 - $57,015
-1,520 Reduced 18.5%
6,695 $222,000
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $21,664 - $28,204
-550 Reduced 6.27%
8,215 $335,000
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $24,842 - $30,782
543 Added 6.6%
8,765 $454,000
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $125,654 - $186,261
3,041 Added 58.7%
8,222 $486,000
Q3 2021

Oct 21, 2021

BUY
$39.25 - $50.42 $2,590 - $3,327
66 Added 1.29%
5,181 $223,000
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $183,679 - $208,078
5,115 New
5,115 $200,000
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $139,745 - $199,665
-5,170 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $170,196 - $193,151
5,170 New
5,170 $203,000
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $167,973 - $217,812
-5,170 Closed
0 $0
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $53,896 - $61,447
-1,401 Reduced 21.32%
5,170 $226,000
Q3 2018

Oct 22, 2018

BUY
$34.47 - $41.81 $34,504 - $41,851
1,001 Added 17.97%
6,571 $290,000
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $172,670 - $190,215
5,570
5,570 $199,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Armbruster Capital Management, Inc. Portfolio

Follow Armbruster Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armbruster Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Armbruster Capital Management, Inc. with notifications on news.